Lakefront Biotherapeutics NV (LKFT) shares outstanding
Lakefront Biotherapeutics NV (LKFT) had 65.90M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 0.4% lower than the 66.14M of fiscal 2024. Figures as of 18 Nov 2026, 12:25 UTC, from Yahoo Finance.
Key facts
- Shares outstanding, fiscal 2025
- 65.90M
- Change on fiscal 2024
- −0.4%
- Highest on record
- 66.14Mfiscal 2024
- Lowest on record
- 65.66Mfiscal 2022
- Fiscal years on record
- 42022–2025
Figures as of . Statements from Yahoo Finance. Figures, not advice.
Lakefront Biotherapeutics NV shares outstanding, in more detail
The market data feed counts 65.90M shares outstanding today.
Across the 4 fiscal years on record (2022–2025), the highest was 66.14M in fiscal 2024 and the lowest 65.66M in fiscal 2022.
Shares outstanding by fiscal year
Lakefront Biotherapeutics NV shares outstanding, year by year
| Fiscal year | Shares outstanding | Change | Year ended |
|---|---|---|---|
| 2025 | 65.90M | 0.4% down | |
| 2024 | 66.14M | 0.4% up | |
| 2023 | 65.88M | 0.3% up | |
| 2022 | 65.66M | — |
Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.
How it is calculated
The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed.
How to read it
A falling count means buybacks are giving each remaining share a larger slice of the company; a rising one means owners are being diluted.
Lakefront Biotherapeutics NV, figure by figure
- Lakefront Biotherapeutics NV market cap
- Lakefront Biotherapeutics NV revenue
- Lakefront Biotherapeutics NV earnings
- Lakefront Biotherapeutics NV earnings per share (EPS)
- Lakefront Biotherapeutics NV P/E ratio
- Lakefront Biotherapeutics NV P/S ratio
- Lakefront Biotherapeutics NV P/B ratio
- Lakefront Biotherapeutics NV free cash flow
- Lakefront Biotherapeutics NV operating margin
- Lakefront Biotherapeutics NV dividend
- Lakefront Biotherapeutics NV total debt
- Lakefront Biotherapeutics NV cash on hand
- Lakefront Biotherapeutics NV total assets
- Lakefront Biotherapeutics NV return on equity (ROE)
- Lakefront Biotherapeutics NV return on invested capital (ROIC)
Lakefront Biotherapeutics NV (LKFT) overview: price, valuation and scorecard
Lakefront Biotherapeutics NV shares outstanding: questions and answers
How many shares does Lakefront Biotherapeutics NV have?
Lakefront Biotherapeutics NV (LKFT) had 65.90M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 0.4% lower than the 66.14M of fiscal 2024. The market data feed counts 65.90M shares outstanding today.
What are the highest and lowest diluted share count figures on record for Lakefront Biotherapeutics NV?
Across the 4 fiscal years on record (2022–2025), the highest was 66.14M in fiscal 2024 and the lowest 65.66M in fiscal 2022.
How is Lakefront Biotherapeutics NV's diluted share count calculated?
The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed. For Lakefront Biotherapeutics NV it is on record here for 4 fiscal years, 2022 to 2025.
Fiscal years are named for the calendar year they end in.
Learn: shares outstanding
All stocks guides →- What market capitalization is, and what it is not
Market capitalization is the share price multiplied by the number of shares outstanding: 1 billion shares at $50 is a $50 billion company. It measures the size the stock market puts on a company's equity today. It is not a sale price, it ignores debt and cash, and index providers often count only the freely traded part, the float.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
Cite this page
Funkfolio, “Lakefront Biotherapeutics NV (LKFT) shares outstanding”, data as of 18 November 2026. https://funkfolio.com/stock/LKFT/shares-outstanding
Underlying data: Yahoo Finance.